| Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer G Liu, A Bollig-Fischer, B Kreike, MJ van de Vijver, J Abrams, SP Ethier, ... Oncogene 28 (50), 4491-4500, 2009 | 224 | 2009 |
| Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing … H Biliran Jr, Y Wang, S Banerjee, H Xu, H Heng, A Thakur, A Bollig, ... Clinical Cancer Research 11 (16), 6075-6086, 2005 | 210 | 2005 |
| An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription A Bollig, RJ Miksicek Molecular endocrinology 14 (5), 634-649, 2000 | 158 | 2000 |
| Genes associated with prostate cancer are differentially expressed in African American and European American men IJ Powell, G Dyson, S Land, J Ruterbusch, CH Bock, S Lenk, M Herawi, ... Cancer epidemiology, biomarkers & prevention 22 (5), 891-897, 2013 | 156 | 2013 |
| Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer A Thakur, KMW Rahman, J Wu, A Bollig, H Biliran, X Lin, H Nassar, ... Molecular Cancer Research 5 (2), 171-181, 2007 | 97 | 2007 |
| Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes ST Guest, ZR Kratche, A Bollig-Fischer, R Haddad, SP Ethier Experimental cell research 332 (2), 223-235, 2015 | 94 | 2015 |
| Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells A Thakur, Y Sun, A Bollig, J Wu, H Biliran, S Banerjee, FH Sarkar, DJ Liao Clinical cancer research 14 (14), 4427-4436, 2008 | 93 | 2008 |
| Transforming Properties of 8p11-12 Amplified Genes in Human Breast CancerTransforming Properties of 8p11-12 Genes ZQ Yang, G Liu, A Bollig-Fischer, CN Giroux, SP Ethier Cancer research 70 (21), 8487-8497, 2010 | 90 | 2010 |
| Expression profile of microRNAs in c-Myc induced mouse mammary tumors Y Sun, J Wu, S Wu, A Thakur, A Bollig, Y Huang, D Joshua Liao Breast cancer research and treatment 118, 185-196, 2009 | 86 | 2009 |
| Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 A Ahmad, KR Ginnebaugh, S Yin, A Bollig-Fischer, KB Reddy, FH Sarkar BMC cancer 15 (1), 1-10, 2015 | 77 | 2015 |
| Minireview: the molecular and genomic basis for prostate cancer health disparities IJ Powell, A Bollig-Fischer Molecular endocrinology 27 (6), 879-891, 2013 | 77 | 2013 |
| Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1 B Bao, AS Azmi, A Aboukameel, A Ahmad, A Bolling-Fischer, S Sethi, ... Journal of Biological Chemistry 289 (21), 14520-14533, 2014 | 70 | 2014 |
| Intronic non-CG DNA hydroxymethylation and alternative mRNA splicing in honey bees P Cingolani, X Cao, RS Khetani, CC Chen, M Coon, A Sammak, ... BMC genomics 14, 1-15, 2013 | 67 | 2013 |
| C-Myc–induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-κB activity in pancreatic cancer cells H Biliran Jr, S Banerjee, A Thakur, FH Sarkar, A Bollig, F Ahmed, J Wu, ... Clinical cancer research 13 (9), 2811-2821, 2007 | 55 | 2007 |
| Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity B Bao, C Mitrea, P Wijesinghe, L Marchetti, E Girsch, RL Farr, JL Boerner, ... Scientific reports 7 (1), 44125, 2017 | 54 | 2017 |
| The role of X-linked genes in breast cancer A Thakur, H Xu, Y Wang, A Bollig, H Biliran, JD Liao Breast cancer research and treatment 93, 135-143, 2005 | 52 | 2005 |
| Racial diversity of actionable mutations in non–small cell lung cancer A Bollig-Fischer, W Chen, SM Gadgeel, AS Wenzlaff, ML Cote, ... Journal of Thoracic Oncology 10 (2), 250-255, 2015 | 48 | 2015 |
| Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice A Thakur, A Bollig, J Wu, DJ Liao Molecular cancer 7, 1-16, 2008 | 48 | 2008 |
| Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice Y Wang, A Thakur, Y Sun, J Wu, H Biliran, A Bollig, DJ Liao Cancer research 67 (8), 3698-3707, 2007 | 45 | 2007 |
| Methylation‐associated silencing of SFRP1 with an 8p11‐12 amplification inhibits canonical and non‐canonical WNT pathways in breast cancers ZQ Yang, G Liu, A Bollig‐Fischer, R Haddad, AL Tarca, SP Ethier International journal of cancer 125 (7), 1613-1621, 2009 | 44 | 2009 |
